BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

HUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric Cancer

The study of savolitinib is a single-arm, multi-center, open-label, Phase II registration study to evaluate the efficacy, safety and tolerability of savoli...

August 29, 2023 | News

3B Scientific acquires iNNOGING Medical

iNNOGING Medical has developed the pioneering cloud-based SaaS solution e Sono for ultrasound simulation that enables users to train and analyze ...

August 29, 2023 | News

BOC Sciences Introduces a Novel XDC Bioconjugation Platform to Advance Biomedical Research

The newly developed XDC bioconjugation platform offered by BOC Sciences introduces a range of advanced technologies and optimized protocols, revolutionizin...

August 25, 2023 | News

EU Commission Approves Pfizer's ABRYSVO™ for Infant and Elderly RSV Protection

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for ABRYSVO™, the company’s bival...

August 25, 2023 | News

SK Bioscience and Vaxxas Partner for Needle-Free Typhoid Vaccine Patch

SK bioscience and Vaxxas have officially entered into a Joint Development Agreement. This collaboration is set to revolutionize vaccine delivery by devel...

August 24, 2023 | News

AGC Biologics Expands Cell Therapy Facilities at Longmont ATMP Campus

AGC Biologics, the world's leading contract research and manufacturing organization (CDMO), announced the addition of three new Grade B cell therapy ...

August 24, 2023 | News

Paradigm Therapeutics Acquires Breakthrough Therapy for EB Treatment

Paradigm Therapeutics Inc., a biopharmaceutical company, announced the completion of the acquisition of the worldwide rights of SD-101, a topical who...

August 23, 2023 | News

CanariaBio's MAb-AR20.5 for Pancreatic Cancer Granted FDA Orphan Drug Designation

CanariaBio Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative immunotherapies for cancer, anno...

August 22, 2023 | News

Hummingbird Bioscience to Present HMBD-001 Combo Strategy for Lung Cancer at 2023 Conference

The poster will highlight the scientific rationale for combining anti-HER3 antibody HMBD-001 with EGFR inhibition and chemotherapy to improve treatment out...

August 22, 2023 | News

Everest Medicines' Partner Calliditas Therapeutics Gets FDA Priority Review for Nefecon® in IgA Nephropathy

"We congratulate our partner Calliditas for being granted priority review by the FDA for full approval and taking a step closer to offering this first-in-d...

August 22, 2023 | Regulatory

FOXO Technologies™ and DataRobot Partner for AI-Driven Human Longevity Research

Epigenetic biomarkers provide valuable insights into the relationships among health, aging, and human longevity. These biomarkers are developed by leveragi...

August 19, 2023 | News

3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling

3Z, holds expertise in developing genetically engineered models of central nervous system disorders, has successfully identified potential ADHD treatments ...

August 19, 2023 | News

Neurophth Begins Phase I/II Trial for Second Gene Therapy with First Patient Dosed

Neurophth is conducting a Phase I/II, multi-region, multi-center, single-arm, open-labeled, dose-finding study aimed at evaluating the safety, tole...

August 18, 2023 | News

MGI Unveils Latest MGISP-NEX and MGIFLP-L50 Automation Systems

MGI, a company committed to building core tools and technology to lead life science, today announced the global launch of MGISP-NEX and MGIFLP-L50 automati...

August 17, 2023 | News

Stay Connected